What question did this study set out to answer?

This research aims to evaluate innovative approaches in gene therapy and editing for type 1 diabetes treatment.

April 25, 2026Diabetes Obesity and Metabolism1 citationsOpen Access

Gene Therapy and Gene Editing in Type 1 Diabetes: CRISPR ‐Based β‐Cell Replacement and Treg Immune Modulation Approaches

TLTzu-Min LinInstitute for Information Industry HCHui‐Fang ChangMackay Memorial Hospital TLTzu-Ching LinInstitute for Information Industry

Puntos clave

This research aims to evaluate innovative approaches in gene therapy and editing for type 1 diabetes treatment.
Explored CRISPR-based techniques for beta-cell replacement
Investigated Treg immune modulation strategies
Addressed translational challenges for clinical application
Demonstrated potential for curative interventions beyond insulin replacement
Identified significant translational hurdles to be addressed for routine clinical use

Resumen

Together, these efforts represent a paradigm shift from symptomatic insulin replacement toward curative interventions, while highlighting the considerable translational hurdles that must be overcome before routine clinical application.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo